New shot for obesity and diabetes passes first safety test
Disease control
Completed
This early study tested a single injection of a new drug called ENT-03S in 49 people who were either obese but otherwise healthy, or had both obesity and type 2 diabetes. The main goal was to check safety and how the drug moves through the body. Participants were randomly assigne…
Phase: PHASE1 • Sponsor: Metabolics Pharma • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC